Table 2.

Relative miR-92, miR-19b, and miR-21 expression in vitreous of patients with PVRL vs patients with vitritis and patients with macular pucker

PVRL (n = 10)Vitritis (n = 40)Macular pucker (n = 7)
REL*SDREL*SDP valueREL*SDP value
miR-92 −7.29 0.65 −11.72 0.81 .0020 −13.60 0.44 <.0001§ 
miR-19b −9.32 0.84 −12.92 0.97 .0250 −15.45 0.50 <.0001§ 
miR-21 −6.78 0.77 −9.45 1.12 .0431 −10.59 0.51 .0025§ 
PVRL (n = 10)Vitritis (n = 40)Macular pucker (n = 7)
REL*SDREL*SDP valueREL*SDP value
miR-92 −7.29 0.65 −11.72 0.81 .0020 −13.60 0.44 <.0001§ 
miR-19b −9.32 0.84 −12.92 0.97 .0250 −15.45 0.50 <.0001§ 
miR-21 −6.78 0.77 −9.45 1.12 .0431 −10.59 0.51 .0025§ 
*

Data are means of RELs (group-wise).

Standard deviation.

The P value is for comparison of expression levels of miR-92, miR-19b, and miR-21 among PVRL patients and vitritis patients and was calculated using the Mann-Whitney U test.

§

The P value is for comparison of expression levels of miR-92, miR-19b, and miR-21 among PVRL patients and macular pucker patients and was calculated using the Mann-Whitney U test.

or Create an Account

Close Modal
Close Modal